Friday, July 10, 2026

Drug profile · INN

cefuroxime

cefuroxime (PHARMACOR CEFUROXIME) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.

FDA: approved TGA: approved NMPA: clinical trials
US status approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — cefuroxime
US status
approved
Class
Route
INJECTION
Patents
1
Programs
1
Data quality
0.84

Quick answer

cefuroxime (PHARMACOR CEFUROXIME) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN cefuroxime
Brand PHARMACOR CEFUROXIME
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved
TGA approved
NMPA clinical trials

Pipeline programs

  1. MGT-RPGR-022 Phase 3 · Janssen-Cilag International N.V · X-Linked Retinitis Pigmentosa caused by mutations in the RPG
  1. CA 3025863

    COMPOSE PHARMACEUTIQUE CONTENANT DU CEFUROXIME

    Expires Wed Jan 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cefuroxime?

cefuroxime (PHARMACOR CEFUROXIME) is an FDA-listed pharmaceutical active ingredient. Associated with Lacuna Pharma Pty Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for cefuroxime?

PHARMACOR CEFUROXIME is a marketed brand name for cefuroxime. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of cefuroxime?

cefuroxime has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.